{
    "id": 2097,
    "fullName": "JAK1 V658F",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "JAK1 V658F lies within the protein kinase domain 1 of the Jak1 protein (UniProt.org). V658F results in constitutive Jak1 activation, increased phosphorylation of Stat5 and Erk, transformation of cultured cells, and tumor formation in mouse models (PMID: 21393331).",
            "references": [
                {
                    "id": 908,
                    "pubMedId": 21393331,
                    "title": "Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21393331"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 3716,
        "geneSymbol": "JAK1",
        "terms": [
            "JAK1",
            "JAK1A",
            "JAK1B",
            "JTK3"
        ]
    },
    "variant": "V658F",
    "createDate": "10/07/2014",
    "updateDate": "10/23/2019",
    "referenceTranscriptCoordinates": {
        "id": 104343,
        "transcript": "NM_002227",
        "gDna": "chr1:g.64846664C>A",
        "cDna": "c.1972G>T",
        "protein": "p.V658F",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 7517,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, SHP099 inhibited proliferation of a hematopoietic cancer cell line harboring JAK1 V658F in culture (PMID: 27362227).",
            "molecularProfile": {
                "id": 2059,
                "profileName": "JAK1 V658F"
            },
            "therapy": {
                "id": 4504,
                "therapyName": "SHP099",
                "synonyms": null
            },
            "indication": {
                "id": 2531,
                "name": "hematologic cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6394,
                    "pubMedId": 27362227,
                    "title": "Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27362227"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 1205,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing JAK1 V658F were sensitive to ATP-competitive JAK inhibitors, such as Jakafi (Ruxolitinib) (PMID: 21393331).",
            "molecularProfile": {
                "id": 2059,
                "profileName": "JAK1 V658F"
            },
            "therapy": {
                "id": 907,
                "therapyName": "Ruxolitinib",
                "synonyms": null
            },
            "indication": {
                "id": 162,
                "name": "cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 908,
                    "pubMedId": 21393331,
                    "title": "Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21393331"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 1163,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cells harboring the JAK1 V658F/F958C double mutation displayed resistance to ATP-competetive JAK inhibitors, such as Jakafi (Ruxolitinib) (PMID: 21393331).",
            "molecularProfile": {
                "id": 2066,
                "profileName": "JAK1 V658F JAK1 F958C"
            },
            "therapy": {
                "id": 907,
                "therapyName": "Ruxolitinib",
                "synonyms": null
            },
            "indication": {
                "id": 162,
                "name": "cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 908,
                    "pubMedId": 21393331,
                    "title": "Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21393331"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2059,
            "profileName": "JAK1 V658F",
            "profileTreatmentApproaches": [
                {
                    "id": 5129,
                    "name": "JAK1 Inhibitor",
                    "profileName": "JAK1 V658F"
                },
                {
                    "id": 5128,
                    "name": "JAK Inhibitor (Pan) - ATP competitive",
                    "profileName": "JAK1 V658F"
                },
                {
                    "id": 5127,
                    "name": "JAK Inhibitor (Pan)",
                    "profileName": "JAK1 V658F"
                },
                {
                    "id": 5130,
                    "name": "JAK1 Inhibitor - ATP competitive",
                    "profileName": "JAK1 V658F"
                }
            ]
        },
        {
            "id": 2066,
            "profileName": "JAK1 V658F JAK1 F958C",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 104339,
            "transcript": "NM_001321854",
            "gDna": "chr1:g.64846664C>A",
            "cDna": "c.1972G>T",
            "protein": "p.V658F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 104342,
            "transcript": "NM_001320923",
            "gDna": "chr1:g.64846664C>A",
            "cDna": "c.1972G>T",
            "protein": "p.V658F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 104343,
            "transcript": "NM_002227",
            "gDna": "chr1:g.64846664C>A",
            "cDna": "c.1972G>T",
            "protein": "p.V658F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 104338,
            "transcript": "NM_001321852",
            "gDna": "chr1:g.64846664C>A",
            "cDna": "c.1972G>T",
            "protein": "p.V658F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 104340,
            "transcript": "NM_001321853",
            "gDna": "chr1:g.64846664C>A",
            "cDna": "c.1972G>T",
            "protein": "p.V658F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 104341,
            "transcript": "NM_001321856",
            "gDna": "chr1:g.64846664C>A",
            "cDna": "c.1972G>T",
            "protein": "p.V658F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 104344,
            "transcript": "NM_001321855",
            "gDna": "chr1:g.64846664C>A",
            "cDna": "c.1972G>T",
            "protein": "p.V658F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}